Non-small cell lung cancer
Conditions
Interventions
Observation group:None
Sponsors
Xi'an Jiaotong University Second Affiliated Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Aged 18 years or older, regardless of gender; 2.Primary non-small cell lung cancer with clear cytopathological/tissue pathological evidence; 3.Presence of lung cancer liver metastasis with available tissue samples; 4.First-time receipt of anti-tumor immunotherapy, with at least one efficacy evaluation conducted during the treatment period; 5.Consent to participate in the study;
Exclusion criteria
Exclusion criteria: 1.Unknown histopathological type; 2.Refusal to participate in the study; 3.Records of anti-tumor treatment are missing, or participation in blinded drug clinical trials results in unknown medication information; 4.Complicated with other malignant tumors that have not been radically resected; 5.Previous receipt of other immunotherapies except immune checkpoint inhibitors;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tumor Immuno-Physical Characteristics; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall Survival (OS);Objective Response Rate (ORR); | — |
Countries
China
Contacts
Public ContactGuo Hui
Xi'an Jiaotong University Second Affiliated Hospital
Outcome results
None listed